Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

Interactive Plaque Dashboard - courtesy HeartFlow
Plaque Analysis
HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease
07/19/2024
“Having access to a patient’s whole coronary picture, with both quantified plaque and physiology, is a game-changer as a clinician. I can reference the cross-sectional views with plaque by type when reviewing my patient’s workup and have...
“Having access to a patient’s whole coronary picture, with both quantified plaque and physiology, is a game-changer as a clinician. I can reference the cross-sectional views with plaque by type when reviewing my patient’s workup and have...
“Having access to a patient’s...
07/19/2024
Cath Lab Digest
Ischemic Stroke
Imperative Care Announces FDA Clearance and Initial Cases of the Zoom 6F Insert Catheters, the First Insert Catheters Built for Stroke
07/17/2024
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the new Zoom 6F Insert Catheters were developed to be more supportive, more torque-able and longer than current vessel selection devices and are offered in three stroke-specific shapes.
Based on physician feedback, the...
07/17/2024
Cath Lab Digest
Peripheral Intervention
FDA Clears Balloon Dilation Scoring and Constraining Platform to Treat Small or Distal Peripheral Vasculature
07/16/2024
“The XO technology has shown effectiveness modifying, cracking, and dilating intimal and medial calcium using low pressures,” said Richard Saxon, MD, FSIR of Tri-City Medical, San Diego, California.
“The XO technology has shown effectiveness modifying, cracking, and dilating intimal and medial calcium using low pressures,” said Richard Saxon, MD, FSIR of Tri-City Medical, San Diego, California.
“The XO technology has shown...
07/16/2024
Cath Lab Digest
Acquisitions
Edwards Lifesciences to Acquire Innovalve
07/15/2024
Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since that time, Innovalve has...
Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an early-stage transcatheter mitral valve replacement (TMVR) company, following its initial investment in 2017. Since that time, Innovalve has...
Edwards Lifesciences announced...
07/15/2024
Cath Lab Digest
New Technology
Sensome Signs Exclusive Commercial Distribution Agreement for Clot-Sensing Guidewire in Japan With Cosmotec
07/10/2024
Sensome’s clot-sensing guidewire integrates the world’s smallest electrical impedance sensor with machine learning and is being developed to instantly identify clot composition and clot length in real-time in order to inform treatment...
Sensome’s clot-sensing guidewire integrates the world’s smallest electrical impedance sensor with machine learning and is being developed to instantly identify clot composition and clot length in real-time in order to inform treatment...
Sensome’s clot-sensing guidewire...
07/10/2024
Cath Lab Digest
Vascular Closure
Cordis Receives FDA Approval for MYNX CONTROL VENOUS Vascular Closure Device
07/09/2024
Leveraging GRIP TECHNOLOGY™, based on hydrophilic, bioinert polyethylene glycol (PEG), the MYNX CONTROL™ VENOUS VCD sealant resorbs 3x faster than collagen-based sealants and provides the quickest time to hemostasis of any venous closure...
Leveraging GRIP TECHNOLOGY™, based on hydrophilic, bioinert polyethylene glycol (PEG), the MYNX CONTROL™ VENOUS VCD sealant resorbs 3x faster than collagen-based sealants and provides the quickest time to hemostasis of any venous closure...
Leveraging GRIP TECHNOLOGY™,...
07/09/2024
Cath Lab Digest
drug-eluting stents
Reflow Medical Enrolls First Patients in Pilot Study of Coronary Sirolimus-Eluting Retrievable Scaffold System (Spur Elute)
07/01/2024
Reflow Medical, Inc. announces the first patient enrollments in “A pilot study of the Drug-Eluting Coronary Spur™ StEnt as a Primary trEatment for in-stent Restenosis (ISR) of the CORONARY arteries” (DEEPER CORONARY, NCT06117150).
Reflow Medical, Inc. announces the first patient enrollments in “A pilot study of the Drug-Eluting Coronary Spur™ StEnt as a Primary trEatment for in-stent Restenosis (ISR) of the CORONARY arteries” (DEEPER CORONARY, NCT06117150).
Reflow Medical, Inc. announces...
07/01/2024
Cath Lab Digest
Philips instantaneous wave-free ratio (iFR)
instantaneous wave-free ratio (iFR)
The Story of How Academics, Industry and Interventionalists Teamed Up to Reduce Cost, Time and Patient Discomfort in Treating Coronary Artery Disease
06/27/2024
Instantaneous wave-free ratio (iFR) is a pressure-derived index that does not require a pharmacological agent. iFR was invented by Dr. Justin Davies from Imperial College Healthcare NHS Trust in the UK, along with the team of clinicians at...
Instantaneous wave-free ratio (iFR) is a pressure-derived index that does not require a pharmacological agent. iFR was invented by Dr. Justin Davies from Imperial College Healthcare NHS Trust in the UK, along with the team of clinicians at...
Instantaneous wave-free ratio...
06/27/2024
Cath Lab Digest
Reprocessing Devices
Innovative Health and US Endovascular Announce Agreement to Drive Cost Savings in Ambulatory Surgery Centers and Office-Based Labs
06/27/2024
Innovative Health, Inc. and US Endovascular announced that they have entered into an agreement that will enable US Endovascular’s partners among ambulatory surgery centers (ASCs) and office-based labs (OBLs) to benefit from the rapidly...
Innovative Health, Inc. and US Endovascular announced that they have entered into an agreement that will enable US Endovascular’s partners among ambulatory surgery centers (ASCs) and office-based labs (OBLs) to benefit from the rapidly...
Innovative Health, Inc. and US...
06/27/2024
Cath Lab Digest
TAVR
TAVR Treatment Remains Low in Bicuspid Aortic Valve Stenosis Patients, Finds GlobalData
06/25/2024
Despite receiving approval, international guidelines still recommend open surgical replacement in populations with bicuspid aortic valve (BAV) disease. As a result, TAVR treatment for BAVs still remains relatively low in comparison to...
Despite receiving approval, international guidelines still recommend open surgical replacement in populations with bicuspid aortic valve (BAV) disease. As a result, TAVR treatment for BAVs still remains relatively low in comparison to...
Despite receiving approval,...
06/25/2024
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement